163 related articles for article (PubMed ID: 28990507)
1. Metabolomics and Heart Diseases: From Basic to Clinical Approach.
Barba I; Andrés M; Garcia-Dorado D
Curr Med Chem; 2019; 26(1):46-59. PubMed ID: 28990507
[TBL] [Abstract][Full Text] [Related]
2. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
3. A practical guide to metabolomic profiling as a discovery tool for human heart disease.
Heather LC; Wang X; West JA; Griffin JL
J Mol Cell Cardiol; 2013 Feb; 55():2-11. PubMed ID: 23231771
[TBL] [Abstract][Full Text] [Related]
4. The emergent role of metabolic phenotyping in dynamic patient stratification.
Lindon JC; Nicholson JK
Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):915-9. PubMed ID: 24905565
[TBL] [Abstract][Full Text] [Related]
5. Application of Metabolomics to Renal and Cardiometabolic Diseases.
Rebholz CM; Rhee EP
Methods Mol Biol; 2020; 2104():401-417. PubMed ID: 31953828
[TBL] [Abstract][Full Text] [Related]
6. Editorial: cardiovascular drug therapy in paediatric age: from metabolomics to clinical practice.
Bassareo PP; Fanos V
Curr Med Chem; 2014; 21(27):3107. PubMed ID: 24606512
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics as a tool to identify biomarkers to predict and improve outcomes in reproductive medicine: a systematic review.
Bracewell-Milnes T; Saso S; Abdalla H; Nikolau D; Norman-Taylor J; Johnson M; Holmes E; Thum MY
Hum Reprod Update; 2017 Nov; 23(6):723-736. PubMed ID: 29069503
[TBL] [Abstract][Full Text] [Related]
8. New insights into cardiovascular and lipid metabolomics.
Giovane A; Balestrieri A; Napoli C
J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
[TBL] [Abstract][Full Text] [Related]
9. [Metabolomic Profiling of Patients With Cardiovascular Diseases].
Belenkov YN; Privalova EV; Kozhevnikova MV; Korobkova EO; Ilgisonis IS; Kaplunova VY; SHakaryants GA; Appolonova SA; Kuharenko AV; Larcova EV; Mesonzhik NV
Kardiologiia; 2018 Sep; 58(9):59-62. PubMed ID: 30295200
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
Ussher JR; Elmariah S; Gerszten RE; Dyck JR
J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine.
Pintus R; Bassareo PP; Dessì A; Deidda M; Mercuro G; Fanos V
Biomed Res Int; 2017; 2017():6970631. PubMed ID: 28758121
[TBL] [Abstract][Full Text] [Related]
13. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.
Hunter WG; Kelly JP; McGarrah RW; Kraus WE; Shah SH
Curr Heart Fail Rep; 2016 Jun; 13(3):119-31. PubMed ID: 27216948
[TBL] [Abstract][Full Text] [Related]
15. The future perspective: metabolomics in laboratory medicine for inborn errors of metabolism.
Sandlers Y
Transl Res; 2017 Nov; 189():65-75. PubMed ID: 28675806
[TBL] [Abstract][Full Text] [Related]
16. [Focus on the Myocardial Hypertrophy from the Perspective of Transcriptomics and Metabolomics].
Shakaryants GA; Kozhevnikova MV; Kaplunova VY; Privalova EV; Lishuta AS; Korobkova EO; Belenkov YN
Kardiologiia; 2020 Mar; 60(4):120-129. PubMed ID: 32394866
[TBL] [Abstract][Full Text] [Related]
17. Computational Strategies for Biological Interpretation of Metabolomics Data.
Xia J
Adv Exp Med Biol; 2017; 965():191-206. PubMed ID: 28132181
[TBL] [Abstract][Full Text] [Related]
18. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
[TBL] [Abstract][Full Text] [Related]
19. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
